{"name": "Peloton Therapeutics",
 "permalink": "peloton-therapeutics",
 "crunchbase_url": "http://www.crunchbase.com/company/peloton-therapeutics",
 "homepage_url": "http://www.pelotontherapeutics.com",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": null,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "jane@jmgcomm.com",
 "phone_number": "415.348.0010",
 "description": "",
 "created_at": "Wed Jul 27 12:28:30 UTC 2011",
 "updated_at": "Thu Jul 28 02:36:42 UTC 2011",
 "overview": "\u003Cp\u003EA peloton is a team of bicyclists who achieve great efficiency of motion through cooperative action. It is also the root of platoon, a nimble military unit with capabilities that exceed the sum of its component parts. Founded by Chairman of Biochemistry Steven L. McKnight of UT Southwestern Medical Center, Peloton Therapeutics represents a unique combination of innovative science, strong financial support from the Cancer Prevention Research Institute of Texas (CPRIT), and seasoned investors and management. Working in close collaboration with scientists at UT Southwestern, Peloton is advancing a promising discovery and development pipeline, comprised of several small molecule-based programs, each with a distinct target and mechanism of action. Peloton\u00e2\u20ac\u2122s vision is to become a major biotech company in Dallas with a passion for discovering and developing novel cancer drugs.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       70],
      "assets/images/resized/0014/6607/146607v1-max-150x150.png"],
     [[216,
       101],
      "assets/images/resized/0014/6607/146607v1-max-250x250.png"],
     [[216,
       101],
      "assets/images/resized/0014/6607/146607v1-max-450x450.png"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$18M",
 "funding_rounds":
  [{"round_code": "a",
    "source_url": "http://www.finsmes.com/2011/07/peloton-therapeutics-completes-18m-series-financing.html?utm_source=feedburner\u0026utm_medium=feed\u0026utm_campaign=Feed%3A+finsmes%2FcNHu+%28FinSMEs%29",
    "source_description": "Peloton Therapeutics Completes $18M Series A Financing",
    "raised_amount": 18000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2011,
    "funded_month": 7,
    "funded_day": 27,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "The Column Group",
         "permalink": "the-column-group",
         "image":
          {"available_sizes":
            [[[150,
               105],
              "assets/images/resized/0004/9539/49539v1-max-150x150.png"],
             [[230,
               162],
              "assets/images/resized/0004/9539/49539v1-max-250x250.png"],
             [[230,
               162],
              "assets/images/resized/0004/9539/49539v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Remeditex Ventures",
         "permalink": "remeditex-ventures",
         "image":
          {"available_sizes":
            [[[148,
               66],
              "assets/images/resized/0019/3757/193757v1-max-150x150.jpg"],
             [[148,
               66],
              "assets/images/resized/0019/3757/193757v1-max-250x250.jpg"],
             [[148,
               66],
              "assets/images/resized/0019/3757/193757v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null}]}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [],
 "external_links":
  []}